This insight helps your clinician design a personalized protocolpossibly using slower escalation, microdose options, or alternative formulationsto reduce nausea risk upfront
Sources ZEPBOUND (tirzepatide) Injection, for subcutaneous use (2022) FDA Approves First Medication for Obstructive Sleep Apnea (December 20th, 2024) MOUNJAROTM (tirzepatide) Injection, for subcutaneous use
Voxs senior correspondent Dylan Scott has been on the health beat for a long time, and every week, hell wade into sticky debates, answer fair questions, and contextualize whats happening in American health care policy
Wegovy for weight management), liraglutide (Victoza for diabetes
Important Safety Information for Ozempic (semaglutide) injection Warning: Risk of Thyroid C-Cell Tumors In studies with mice and rats, semaglutide (the active ingredient in Ozempic and Wegovy) caused thyroid tumors, including thyroid cancer